Volver a Agenda
SESSION 4: SIGNAL MANAGEMENT (PART 2)
Session Chair(s)
Georgy Genov, MD
Head of Pharmacovigilance Office
European Medicines Agency, Netherlands
Menno Van Der Elst, PHARMD, PHD
Head of EU Committees Department
MEB, Netherlands
The signal management session will continue with a presentation on the processes put in place by a marketing authorisation holder involved in the signal management pilot. Signal management key performance indicators (KPIs) from an industry perspective will be also discussed. The session will conclude with a dedicated question and answer session for which participants are invited to send questions by 23 February 2018 to emaevents@diaglobal.org
Speaker(s)
MAHs processes as part of the signal management pilot
Magnus Ysander, MD
AstraZeneca, Sweden
EU & UK QPPV & Head Pharmacovigilance Excellence
Signal Management KPIs from an industry perspective
David John Lewis, PHD
Novartis Pharma Gmbh, Switzerland
Former Head QPPV PRRC Office, Patient Safety & Pharmacovigilance
¿Tiene una cuenta?